Lymphopenia: Clinical Trials

11 trials for Lymphopenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 terminated. 11 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Terminated 11
Phase 11Terminated 1

Follow Lymphopenia: new trials by email Literature Review of Lymphopenia trials Research Report on Lymphopenia

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)
Interleukin-7, PLACEBO - COVID-19, Lymphocytopenia
Phase 2TerminatedRevimmune42021-03-012024-04-12
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )
CYT107, Placebo - COVID-19, Lymphocytopenia
Phase 2TerminatedRevimmune102020-12-202024-04-11
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )
CYT107, Placebo - COVID-19, Lymphocytopenia
Phase 2TerminatedRevimmune262020-09-152022-04-08
Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection
Thymalfasin - Covid19
Phase 2TerminatedRhode Island Hospital562020-09-102023-02-14
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort
Interleukin-7, Placebo - COVID-19, Lymphocytopenia
Phase 2TerminatedRevimmune342020-06-082022-04-08
InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort
Interleukin-7, Placebos - COVID-19, Lymphocytopenia
Phase 2TerminatedRevimmune352020-05-142022-04-07
Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients
CYT107, Placebos - Sepsis, Severe
Phase 2TerminatedRevimmune212019-06-012021-10-27
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Cyclophosphamide, Fludarabine Phosphate, Laboratory Biomarker Analysis - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission
Phase 2TerminatedRoswell Park Cancer Institute312017-12-072025-07-04
Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
Promacta, blood drawing in patients with WAS, blood drawing in healthy controls - Wiskott-Aldrich Syndrome, Thrombocytopenia
Phase 2TerminatedWeill Medical College of Cornell University242009-06-012019-03-18
Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)
CYT107 - Idiopathic CD4+ T-Lymphocytopenia
Phase 1 / Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)212009-02-012015-10-15
Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
Cyclophosphamide Dose Level 1, Cyclophosphamide Dose Level 2, Cyclophosphamide Dose Level 3 - Stem Cell Transplantation, Bone Marrow Transplantation
Phase 2TerminatedChildren's Hospital Los Angeles202007-02-012017-02-27

Narrower conditions

COVID-19 (6)  ·  Wiskott-Aldrich Syndrome (3)  ·  Anemia, Diamond-Blackfan (2)  ·  Granulomatous Disease, Chronic (2)  ·  Thalassemia (2)  ·  Anemia, Aplastic (1)  ·  Anemia, Sickle Cell (1)  ·  Congenital amegakaryocytic thrombocytopenia (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemoglobinuria, Paroxysmal (1)  ·  Hemorrhage (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)

Broader conditions

Cytopenia (11)  ·  Hematologic Diseases (11)  ·  Hemic and Lymphatic Diseases (11)  ·  Immune System Diseases (11)  ·  Leukocyte Disorders (11)  ·  Leukopenia (11)  ·  Immunologic Deficiency Syndromes (10)  ·  Infections (7)  ·  Coronaviridae Infections (6)  ·  Coronavirus Infections (6)  ·  Lung Diseases (6)  ·  Nidovirales Infections (6)  ·  Pneumonia (6)  ·  Pneumonia, Viral (6)  ·  RNA Virus Infections (6)

Interventions

Interleukin-7 (5)  ·  Sodium Chloride (5)  ·  Cyclophosphamide (2)  ·  Blood Specimen Collection (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Saline Solution (1)  ·  Thymalfasin (1)  ·  Trace amine-associated receptor 1 (1)  ·  Whole-Body Irradiation (1)  ·  eltrombopag (1)  ·  fludarabine phosphate (1)

Sponsors

Revimmune (6)  ·  Children's Hospital Los Angeles (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Rhode Island Hospital (1)  ·  Roswell Park Cancer Institute (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (7)  ·  France (2)  ·  Brazil (1)  ·  United Kingdom (1)

Top investigators

Eleftherios Mylonakis, MD PhD FIDSA (1)  ·  James B Bussel, MD (1)  ·  Manu Shankar-Hari, MD PhD (1)  ·  Marcel van den Brink, MD, PhD (1)  ·  Neena Kapoor, M.D. (1)  ·  Philip McCarthy, MD (1)  ·  Richard Hotchkiss, MD (1)  ·  Richard Hotchkiss, MD PhD (1)  ·  Steve Pastores, MD (1)  ·  Virginia M Sheikh, M.D. (1)

Results publications

PMID 39903535, PMID 32031570, PMID 32171076, PMID 29515037, PMID 23053510, PMID 18946659, PMID 25459642, PMID 26224646, PMID 26675348, PMID 36056913, PMID 36906875